Asoprisnil

DRUG12 trials

Sponsors

Abbott

Conditions

EndometriosisFibroid UterusLeiomyomaMenorrhagiaMetrorrhagiaUterine Fibroids

Phase 2

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

CompletedNCT00150644

AbbottLeiomyoma, Uterine Fibroids

Start: 2003-07-31End: 2005-05-31Updated: 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Women With Endometriosis.

CompletedNCT00160433

AbbottEndometriosis

Start: 2002-08-31End: 2003-06-30Updated: 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

CompletedNCT00160446

AbbottEndometriosis

Start: 2000-05-31End: 2001-07-31Updated: 2008-05-29

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

CompletedNCT00160420

AbbottEndometriosis

Start: 2002-12-31End: 2004-07-31Updated: 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

CompletedNCT00160459

AbbottLeiomyoma

Start: 2000-05-31End: 2001-07-31Updated: 2008-05-29

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

CompletedNCT00156182

AbbottLeiomyoma

Start: 2001-04-30End: 2001-12-31Updated: 2009-03-04

Phase 3

Treatment of Uterine Fibroids With Asoprisnil(J867)

CompletedNCT00152269

AbbottLeiomyoma, Menorrhagia, Metrorrhagia

Start: 2002-07-31End: 2005-01-31Updated: 2008-05-29

A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

CompletedNCT00152256

AbbottFibroid Uterus, Leiomyoma, Menorrhagia +2

Start: 2003-09-30End: 2005-02-28Updated: 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

CompletedNCT00160381

AbbottLeiomyoma, Menorrhagia, Metrorrhagia

Start: 2002-09-30End: 2005-01-31Updated: 2008-05-29

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

CompletedNCT00156195

AbbottLeiomyoma, Menorrhagia, Metrorrhagia

Start: 2003-09-30End: 2007-01-31Updated: 2008-05-29

Safety of Treatment of Uterine Fibroids With Asoprisnil

CompletedNCT00156208

AbbottFibroid Uterus, Leiomyoma, Menorrhagia +2

Start: 2004-04-30End: 2006-12-31Updated: 2008-05-29

Study of Asoprisnil in the Treatment of Uterine Fibroids.

CompletedNCT00156156

AbbottFibroid Uterus, Leiomyoma, Menorrhagia +2

Start: 2004-11-30End: 2007-02-28Updated: 2008-05-28

Related Papers

Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials

Human Reproduction2019-02-1830 citations

A 12-month extension study to evaluate the safety and efficacy of asoprisnil in women with heavy menstrual bleeding and uterine fibroids

Human Reproduction Open2019-01-019 citations

Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN.

2009-01-2719 citations